HMS — Q3 2017 Earnings Presentation
12 slides from HMS's earnings presentation, Nov 3, 2017
Slide 1: Q3 2017 Investor Presentation
November 3, 2017 Q3 2017 Investor Presentation
Slide 2: Disclaimers: Forward-Looking Statements
Disclaimers FORWARD - LOOKING STATEMENTS . The financial results in this presentation reflect preliminary results, which are not final until our Form 10 - Q for the quarter ended September 30 , 2017 is filed with the Securities and Exchange Commission . This presentation contains "forward - looking
Slide 3: Presentation Outline
Presentation Outline HMSY Q3 2017 Investor Presentation / November 3, 2017 Q3 2017 Financial Results ▪ Financial Performance Highlights ▪ Quarterly Financial Information ▪ Quarterly Market and Product Revenue 1 - 3 Commercial Business ▪ 2015 - 2017 Quarterly Revenue ▪ Q3 Commercial Sales 4 - 5 State
Slide 4: Q3 2017 Financial Performance Highlights
HMSY Q3 2017 Investor Presentation / November 3, 2017 / 1 Financial Performance Highlights ▪ GAAP EPS of $0.07 per diluted share ▪ Adjusted EPS of $0.19 per diluted share 1 ▪ Q3 revenue was $125.7 million - an increase of $2.8 million or 2.3% year - over - year 2 ▪ Q3 commercial health plan revenue
Slide 5: Quarterly Financial Information
HMSY Q3 2017 Investor Presentation / November 3, 2017 / 2 Q3 2017 Financial Results Quarterly Financial Information (Unaudited, $ in thousands, except per share amounts) 1 As revised. Refer to “Part II, Item 8. Consolidated Financial Statements and Supplementary Data, Notes to the Consolidated Finan
Slide 6: Quarterly Market and Product Revenue
HMSY Q3 2017 Investor Presentation / November 3, 2017 / 3 Q3 2017 Financial Results Quarterly Market and Product Revenue (Unaudited, $ in millions) 1 As revised. Refer to “Part II, Item 8. Consolidated Financial Statements and Supplementary Data, Notes to the Consolidated Financial Statements” footn
Slide 7: Quarterly Commercial Revenue 2015-2017
HMSY Q3 2017 Investor Presentation / November 3, 2017 / 4 Quarterly Commercial Revenue 2015 - 2017 (Unaudited, $ in thousands) 1 Amounts reflect revised numbers. Refer to “Part II, Item 8. Consolidated Financial Statements and Supplementary Data, Notes to the Consolidated Financial Statements” footn
Slide 8: Q3 2017 Commercial Sales
HMSY Q3 2017 Investor Presentation / November 3, 2017 / 5 ▪ New business: products sold to new commercial members covering ~0.7 million lives added during Q3’17 1 ▪ Additional business: products sold to current commercial customers covering approximately ~19.2 million lives in Q3’17 2 Q3 2017 Commer
Slide 9: State Government Business: New Medicaid Enrollment Through August 2017
State Government Business New Medicaid Enrollment Through August 2017 1 1 CMS Medicaid & CHIP: August 2017 Monthly Applications, Eligibility Determinations and Enrollment Report, October 31, 2017. This analysis compares additional Medicaid enrollment of ~14.1 million lives reported through 8/31/17 t
Slide 10: Updated Outlook for Full-Year 2017
▪ Total Company fourth quarter revenue of ~ $ 135 - $ 140 million and total annual revenue of ~ $ 508 - $ 513 million ▪ Full year operating margin improvement of 125 - 150 basis points 1 was largely dependent upon projected revenue growth and will not be achieved ▪ Full year operating cash flow of $
Slide 11: Reconciliation of Net Income to GAAP EPS / Adjusted EPS
HMSY Q3 2017 Investor Presentation / November 3, 2017 / 8 Reconciliation of Net Income to GAAP EPS (Diluted)/ Adjusted EPS (Diluted ) The Company believes that the non - GAAP financial measure above provides useful information to the Company's management, investors and other interested parties about
Slide 12: hms.com
Q hms’ Enterprising healthcare Hog hms.com